Our Services
Cancer Services
Stevens Tumor Registry Report
Tumor Registry Report for Stevens Hospital, 2005 data
The tumor registry is one of the major components of our comprehensive cancer program at Stevens Hospital. The registry staff, under the supervision of the Cancer Control Committee, is responsible for maintaining state and national cancer-reporting requirements, coordinating tumor conferences, and providing support for all cancer program activities required for accreditation by the American College of Surgeons Commission on Cancer.
The registry has been collecting data on all cancer patients diagnosed or treated at Stevens Hospital since Jan. 1, 1974. Data collected includes patient demographics, cancer identification, treatments and lifetime follow-up. These data contribute to treatment planning, staging and the continuity of care for patients.
Accurate and complete registry data are the underpinnings that permit Stevens to plan and optimize its cancer program.
There were 544 new cancer cases at Stevens Hospital in 2005. The charts below show the distribution of cancer cases by site and gender in comparison with national data.
2005 Cancer Frequency by Site and Gender
Male
| Site | Stevens | National |
| Prostate | 31% | 33% |
| Lung and Bronchus | 12% | 13% |
| Colon and Rectum | 14% | 10% |
| Urinary Bladder | 4% | 7% |
| Melanoma | 2.4% | 5% |
| Non-Hodgkin’s Lymphoma | 3% | 4% |
| Oral Cavity | 3.2% | 3% |
| Pancreas | 1.6% | 2% |
| All Others | 29% | 23% |
Female
| Site | Stevens | National |
| Breast | 40% | 32% |
| Lung and Bronchus | 12% | 12% |
| Colon and Rectum | 10% | 11% |
| Uterine Corpus | 3% | 6% |
| Non-Hodgkin’s Lymphoma | 2% | 4% |
| Melanoma | 3% | 4% |
| Ovary | 1.4% | 3% |
| Thyroid | 1.4% | 3% |
| All Others | 27% | 25% |
Source: American Cancer Society cancer facts and figures—2005
The bar graph below highlights our five most frequent sites: breast, prostate, lung, colorectal and bladder. Stevens’ incidence of breast cancer is 7.2 percent higher than the national rate, and our prostate cancer is 2.6 percent lower. Lung, colorectal and bladder cancers are comparable.
Annual follow-up is an important function of the Tumor Registry. Lifetime follow-up provides benefits by reminding attending physicians and patients that routine medical examinations are encouraged. This process may potentially bring 'lost' patients back under medical supervision.
Continued surveillance ensures early detection of a possible recurrence or a new primary malignancy. Follow-up also provides a valid measurement of outcome.
There are 12,761 cases currently maintained in our cancer registry. Deceased cases account for 55 percent (figure 3). Of the 45 percent living cases, only 12 percent are lost to follow-up.
Registry Follow-up, Nov. 2006
Source: Stevens Hospital Cancer Registry estimated cases, cancer facts and figures—2005.
